Novartis, Pfizer join forces on potentially lucrative fatty liver disease
ZURICH/NEW YORK: Novartis and Pfizer are teaming up to develop treatments for a liver disease⦠Read More
7 years ago
ZURICH/NEW YORK: Novartis and Pfizer are teaming up to develop treatments for a liver disease⦠Read More